Event Details
Event: 1st Meeting of the Irish Institute for Metal-Based Drugs (IIMBD)
Date: September 20, 2007
Venue: Houston Theatre, RCSI
Programme
14:00 – 14:10 | Opening of the Meeting Prof. Kevin B. Nolan (RCSI) |
14:10 – 14.40 | Response of Candida albicans to silver-based antifungal drugs Dr. Kevin Kavanagh and Dr. Malachy McCann (NUIM) |
14.40 – 15.10 | Novel metal-based coumarins – chemistry and anti-cancer activity Dr. Denise Egan and Dr. Maureen Walsh (ITT) |
15.10 – 15:35 | Novel titanocene anticancer drugs Dr. Matthias Tacke and Dr. William Watson (UCD) |
15:35 – 16.00 | Coffee Break |
16.00 – 16.25 | Reactions of the anticancer molybdocene dichloride with biomolecules Dr. Andrea Erxleben (NUIG) |
16:25 – 16:50 |
Palladium and platinum iminophosphines: potential anticancer agents Dr. Orla Ni Dhubhghaill (UCC) |
16:50 – 17.15 | Pt- and Ru-hydroxamates: NO-donors and in vitro anti-tumour activity Dr. Celine Marmion (RCSI) |
17.15 – 17.45 | Simple Copper Carboxylates: biomimetics with anticancer activity Prof. Mick Devereux and Dr Denis O’Shea (DIT) |
17:45 – 18:15 | Round Table Discussion |
Followed by a wine reception
All welcome to attend
Please confirm attendance with pwhyte@rcsi.ie
*The IIMBD was recently formed by researchers working in the area of metal-based drugs. The
mission of IIMBD is to promote high quality research on metal-based therapies and to raise
awareness of their potential benefits for society. IIMBD welcomes membership from researchers
working in the area with a view to developing future collaborations and joint research applications.